Hamps Bio Limited (BSE: 544312) is a Surat, Gujarat-based company in the Pharmaceuticals industry. With a market capitalisation of ₹22 Cr, it ranks #4,270 by market cap among the 6,197 Indian listed companies on FinBizNet, and #58 of 63 in Pharmaceuticals. At ₹25.50 (as of 10 Nov 2026), the share price is 4.1% below its 52-week high of ₹26.58 and 90.9% above its 52-week low of ₹13.36. The share price is down 1.0% over one year and up 5.2% over three months.
| Current Price | ₹25.50 |
|---|---|
| Market Cap | ₹22 Cr |
| BSE Code | 544312 |
| Sector | Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals |
| Sub-Industry | Biotechnology and Life Sciences > Pharmaceuticals |
| P/E Ratio | Not meaningful (loss) |
| Return on Assets | -2.22% |
| 52-Week Range | ₹13.36 – ₹26.58 |
| 1-Year Price Change | -1.0% |
| 3-Month Price Change | +5.2% |
| Beta (1Y) | 0.6 |
| Headquarters | Surat, Gujarat |
| Website | hampsbio.com |
Delivery averaged 97.2% of traded volume across 6 BSE sessions (16 Oct 2026 – 2 Nov 2026).
Hamps Bio Limited provides pharmaceutical, freeze dried, and frozen products in India and internationally. The company offers nutrition supplement, injection, pediatric care, toothpaste, mouth wash, antiacid/PPI, painkiller/anti-inflammatory, hematantic/calcium supplement, and antibiotic/antibacterial/antifungal pharmaceutical products. It also offers dry freeze food products, including ready to eat food, juices, ice cream powder, smoothie, tea, fruit snacks, milk related, and other dry food products. The company sells its products under the HAMPS and FzyEzy brands through distribution network and e-commerce platform. Hamps Bio Limited was incorporated in 2007 and is based in Surat, India.
1. Pharma Products-This segment engages in manufacturing, trading, and distributing pharmaceutical formulation products. 2. Freeze Dried Products-This segment engages in manufacturing freeze dried and frozen products, including fruits, vegetables, herbs, flowers, etc. 3. NA-NA 4. NA-NA
1. Freeze Dried Products-47.7% 2. Pharma Products-52.3%
| Company | Market Cap | P/E | ROE | Latest Qtr Revenue | 1Y Change |
|---|---|---|---|---|---|
| Abbott India Ltd. | ₹54,788 Cr | 35.3 | 34.46% | ₹1,814 Cr | -8.2% |
| Ajanta Pharma Limited | ₹42,432 Cr | 40.2 | 25.39% | ₹1,794 Cr | +35.7% |
| Emcure Pharmaceuticals Ltd | ₹35,726 Cr | 38.6 | 19.57% | ₹2,820 Cr | +67.0% |
| Piramal Pharma Ltd | ₹31,892 Cr | n/m | -4.00% | ₹2,617 Cr | +21.7% |
| RUBICON RESEARCH LIMITED | ₹27,601 Cr | 108.9 | 19.14% | ₹576 Cr | +186.9% |
| Caplin Point Laboratories Ltdte | ₹17,770 Cr | 27.8 | 19.94% | ₹610 Cr | +25.0% |
| Pfizer Ltd. | ₹16,646 Cr | 23 | 17.16% | ₹727 Cr | -24.3% |
| Eris Lifesciences Ltd | ₹16,096 Cr | 25.6 | 18.07% | ₹892 Cr | -21.1% |
| Hamps Bio Limited | ₹22 Cr | n/m | — | — | -1.0% |
Listed by market capitalisation. Ratios are shown for context only.
Hamps Bio Limited is trading at ₹25.50, with a market capitalisation of ₹22 Cr.
Hamps Bio Limited operates in the Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals space (Biotechnology and Life Sciences > Pharmaceuticals).
Hamps Bio Limited is listed on the BSE under the scrip code 544312.
Hamps Bio Limited's share price is down 1.0% over one year and up 5.2% over three months. Its 52-week range is ₹13.36 to ₹26.58.
Data as of 10 Nov 2026. Descriptive market data only — not investment advice.